Drugs for Older Americans Rose an Average of 15.5% in 2015 According to AARP Report | Pharma Marketing Network
Home Blog Drugs for Older Americans Rose an Average of 15.5% in 2015 According...
Drugs for Older Americans Rose an Average of 15.5% in 2015 According to AARP Report
Retail prices for brand name prescription drugs widely used by older Americans rose by an average of 15.5% in 2015—almost 130 times faster than the 0.1% general inflation rate—according to a new AARP Public Policy Institute (PPI) report released today.
AARP’s Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006-2015, shows that the average annual cost for one brand name drug used on a chronic basis now exceeds $5,800. Five of the six drugs with the highest cumulative price increases over the study period were marketed by Valeant Pharmaceuticals. The retail price of Valeant’s anti-anxiety drug, Ativan 1 mg tablets, increased by 2,873% between 2006 and 2015.
Which companies raised prices the most? Crooked Valeant, of course, tops the list. But can you guess who is #2, #3, etc? Click “Read more” for the answer.
I’m surprised the Lundbeck is #2 (see chart below). Out of the 48 companies assessed for their corporate reputation by patient groups in 2015, Lundbeck snagged third place, ahead of Johnson & Johnson, arguably the most beloved pharma company in the world (for more on that, read “Pharma’s Rep Among Patient Groups at 4-Year High“).
Retail prices increased for 97% of the 268 brand name prescription drugs in the study’s market basket.
Previous articleFlowchart: How Pharma Can Handle Every Type of Comment on Social Media
Next articleFDA Cites TV Ads for “Compelling” “Attention-Grabbing” Distractions That Undermine Communication of Risks